This story originally ran on Nov. 18.
Proteome Sciences announced this week that it is partnering with Irish pharmaceutical services firm Icon to offer biomarker discovery and validation work in support of drug development efforts.
This story originally ran on Nov. 18.
Proteome Sciences announced this week that it is partnering with Irish pharmaceutical services firm Icon to offer biomarker discovery and validation work in support of drug development efforts.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.